Inhibrx
INBX
#5378
Rank
โ‚น122.53 B
Marketcap
โ‚น8,425
Share price
4.52%
Change (1 day)
566.52%
Change (1 year)

Revenue for Inhibrx (INBX)

Revenue in 2025 (TTM): โ‚น0.12 Billion

According to Inhibrx's latest financial reports the company's current revenue (TTM ) is โ‚น0.12 Billion. In 2024 the company made a revenue of โ‚น17.15 Million a decrease over the revenue in the year 2023 that were of โ‚น0.13 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Inhibrx from 2023 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น0.12 B599.45%
2024 โ‚น17.15 M-87.25%
2023 โ‚น0.13 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA